Cargando…
Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats
BACKGROUND: The development of analgesic tolerance following chronic morphine administration can be a significant clinical problem. Preclinical studies demonstrate that chronic morphine administration induces spinal gliosis and that inhibition of gliosis prevents the development of analgesic toleran...
Autores principales: | Mattioli, Theresa-Alexandra M, Milne, Brian, Cahill, Catherine M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862024/ https://www.ncbi.nlm.nih.gov/pubmed/20398374 http://dx.doi.org/10.1186/1744-8069-6-22 |
Ejemplares similares
-
Toll-Like Receptor 4 Mutant and Null Mice Retain Morphine-Induced Tolerance, Hyperalgesia, and Physical Dependence
por: Mattioli, Theresa Alexandra, et al.
Publicado: (2014) -
Low-Dose Naltrexone in Rheumatological Diseases
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2023) -
Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
por: Farahmand, S, et al.
Publicado: (2010) -
Low-Dose Naltrexone for Pruritus in Systemic Sclerosis
por: Frech, Tracy, et al.
Publicado: (2011) -
Low-dose naltrexone as a treatment for chronic fatigue syndrome
por: Bolton, Monica Jane, et al.
Publicado: (2020)